Skip to main content
OpenTrials
Completed

NCT Number: NCT05193357

Home-based Intermittent Pneumatic Compression Therapy for Gynecologic Cancer

Investigators conducted a prospective study of cancer patients to investigate the efficacy, quality of life, satisfaction, and safety of a home-based intermittent pneumatic compression (IPC) device during the maintenance phase of lower extremity lymphedema. This device has a unique mode designed to mimic the manual lymphatic drainage (MLD) technique and thereby gently facilitate lymphatic draining of proximal extremities.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Gynecologic Cancer Lymphedema of Leg

Age range

20 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Samsung Medical Center

Seoul, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • stage 3 chronic unilateral secondary leg lymphedema
  • aged 20-70 years
  • underwent 1-2 cycle of treatment of decongestive phase with current inter-limb volume difference of more than 10%
  • stable limb-volume change (within 10%) during the preceding 3 months
  • capacity for self-maintenance care for lymphedema (multilayer limb bandaging, compression garments, and MLD)

Exclusion criteria

  • bilateral leg lymphedema
  • current cancer metastasis
  • ongoing chemotherapy or radiation therapy
  • acute inflammation
  • venous thrombosis, or chronic venous insufficiency
  • systemic etiologies of edema
  • congestive heart failure
  • patients taking medication that influenced body fluid or electrolytes

Treatment and study plan

home-based intermittent pneumatic compression (IPC) device

Device

During the intervention, two programmed modes were used. The first mode, which mimics the MLD massage technique, begins with the inflation of the proximal chamber. After reaching the target pressure, the next chamber consecutively inflates while the initially inflated proximal chamber deflates. The inflation time of each chamber is 3 seconds with holding time of 1 second. The deflation and resting time of each chamber is 7 seconds (pressure setting: 40-60 mmHg). After 30 minutes of the first mode, the second mode, which is the conventional mode of sequential inflation from distal to proximal chambers while sustaining the pressure of the previously inflated chambers, was applied for 30 minutes (pressure setting: 80-100 mmHg, inflation time of each chamber: 6 seconds, holding time: 1 second, deflation time of each chamber: 7 seconds). Participants were instructed to use the IPC device with that 1-hour cycle twice a day for four weeks.

Primary outcomes

  1. Change of Inter-limb volume difference ratio

    Time frame: Baseline, after 1 month (4-week)

    Investigators measured three leg volumes: the distal leg volume (distal volume: from the smallest circumference at the ankle (B-measure) to the calf circumference right below the knee bend (D-measure)), the whole leg volume (limb volume without the foot up to the mid-thigh region (F-measure)), and the proximal leg volume (subtraction of the distal leg volume from the whole leg volume)

Secondary outcomes

  1. Change of Quality of life (Lymph-ICF-LL)

    Time frame: Baseline, after 1 month (4-week)

    Lymphedema Functioning, Disability, and Health Questionnaire for Lower Limb Lymphedema (Lymph-ICF-LL).

    Questionnaire contains 28 questions divided into 5 domains: physical function, mental function, general tasks/household activities, mobility activities, and life domains/social life. Each question is scored from 0 (not at all) to 10 (a lot), with lower scores representing better QOL. The total scores and 5 domain scores were calculated by summation.

  2. Participant satisfaction questionnaire

    Time frame: after 1 month (4-week)

    The questionnaire contained 6 items related to the subjective effects of the IPC device related to volume reduction, pain, heaviness, skin hardness, ease of use, and overall satisfaction with the home therapy offered by the device. Each question was answered using a 5-point scale from 1 (not at all) to 5 (very much).

Sponsors and collaborators

Lead sponsor

Samsung Medical Center

Other

Collaborators

  • Ministry of Health, Republic of Korea

Registry information

Official study title

Home-based Intermittent Pneumatic Compression Therapy: the Impact in Chronic Leg Lymphedema in Patients Treated for Gynecologic Cancer

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Jan 14, 2022
Registry last updated
Jan 14, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.